TNF and COVID-19: Additionally, increased anti-fibrinolytic PAI-1 and fibrinolytic t-PA by S1 in the presence of TNF-α is concordant with a recent report showing higher levels of PAI-1 and tPA that were associated with worse respiratory outcomes in COVID-19 patients [64], indicating complex fibrinolytic alterations in COVID-19.